Stay updated on Pembrolizumab and Binimetinib in TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.

Latest updates to the Pembrolizumab and Binimetinib in TNBC Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this appears to be a versioning update rather than a substantive change to study details. No study data, eligibility criteria, or outcomes were altered.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added. The site’s previous funding-status notice and an older revision entry (v3.4.1) were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding notice about data currency and NIH operations. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedGlossary toggle was added and several metadata items were updated (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), with corresponding deletions of older phrasing/values (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page version was updated from v3.3.3 to v3.3.4; no changes to study content, results, or user-facing functionality were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a dedicated Locations section featuring a Florida site and updated the labeling from 'Florida Locations' to a general 'Locations' heading. Removed the HHS Vulnerability Disclosure link.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Binimetinib in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.